PPBP

pro-platelet basic protein, the group of Receptor ligands

Basic information

Region (hg38): 4:73985966-73988276

Previous symbols: [ "THBGB1" ]

Links

ENSG00000163736NCBI:5473OMIM:121010HGNC:9240Uniprot:P02775AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PPBP gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPBP gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
6
clinvar
6
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 6 0 0

Variants in PPBP

This is a list of pathogenic ClinVar variants found in the PPBP region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-73987316-T-C not specified Uncertain significance (Dec 09, 2023)3217050
4-73987334-C-T not specified Uncertain significance (Aug 17, 2022)2308128
4-73987367-G-C not specified Uncertain significance (Dec 24, 2024)3782165
4-73987599-T-C not specified Uncertain significance (Feb 13, 2025)3782168
4-73987608-A-G not specified Uncertain significance (Mar 06, 2025)3782166
4-73987617-G-A not specified Uncertain significance (Aug 28, 2023)2589365
4-73987628-T-C not specified Uncertain significance (Sep 08, 2024)3423367
4-73988024-G-A not specified Uncertain significance (Jul 10, 2024)3423368
4-73988033-A-C not specified Uncertain significance (May 17, 2023)2521787
4-73988060-C-T not specified Uncertain significance (Feb 13, 2025)3782167

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PPBPprotein_codingprotein_codingENST00000296028 31160
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.05770.727125660031256630.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.019167.71.340.00000336827
Missense in Polyphen2719.1881.4071269
Synonymous-0.3573027.61.090.00000146258
Loss of Function0.78123.600.5561.50e-752

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002640.0000264
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: LA-PF4 stimulates DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by human synovial cells. NAP-2 is a ligand for CXCR1 and CXCR2, and NAP-2, NAP-2(73), NAP-2(74), NAP-2(1-66), and most potent NAP-2(1-63) are chemoattractants and activators for neutrophils. TC-1 and TC-2 are antibacterial proteins, in vitro released from activated platelet alpha-granules. CTAP-III(1-81) is more potent than CTAP-III desensitize chemokine-induced neutrophil activation. {ECO:0000269|PubMed:10877842, ECO:0000269|PubMed:7890771, ECO:0000269|PubMed:8950790, ECO:0000269|PubMed:9794434}.;
Pathway
Chemokine signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);Chemokine signaling pathway;Signaling by GPCR;Neutrophil degranulation;Signal Transduction;Innate Immune System;Immune System;Chemokine receptors bind chemokines;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis;G alpha (i) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.386

Intolerance Scores

loftool
0.527
rvis_EVS
-0.14
rvis_percentile_EVS
42.88

Haploinsufficiency Scores

pHI
0.348
hipred
N
hipred_score
0.112
ghis
0.594

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.732

Gene Damage Prediction

AllRecessiveDominant
MendelianLowLowLow
Primary ImmunodeficiencyMediumLowMedium
CancerLowLowLow

Mouse Genome Informatics

Gene name
Ppbp
Phenotype
hematopoietic system phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype;

Gene ontology

Biological process
platelet degranulation;inflammatory response;immune response;G protein-coupled receptor signaling pathway;regulation of signaling receptor activity;neutrophil chemotaxis;leukocyte chemotaxis;defense response to bacterium;neutrophil degranulation;positive regulation of cell division;antimicrobial humoral immune response mediated by antimicrobial peptide;chemokine-mediated signaling pathway;cellular response to lipopolysaccharide;glucose transmembrane transport
Cellular component
extracellular region;extracellular space;platelet alpha granule lumen;tertiary granule lumen
Molecular function
glucose transmembrane transporter activity;protein binding;chemokine activity;growth factor activity